Search

everythinglearnresearchcommunity

for

Search:↓

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

A five-month-old boy with Omenn syndrome successfully recovered after a stem cell transplant with reduced intensity conditioning.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

A specific immune response helps control mite populations on the skin, maintaining healthy hair follicles.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Pure carbon nanotubes are safe for mice, but impure ones cause immune issues and hair loss.

Targeting Vδ1+T-cells may help treat alopecia areata.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

DPCP helps treat severe hair loss, but 5% minoxidil doesn't add benefits.

Two mouse mutations cause similar hair loss despite different skin changes.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Hamilton scale imprecise, hair shaft diameter decreases, stem cell transplant regrows hair, ECP ineffective for alopecia areata universalis.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Tight junctions are key for skin protection and controlling what gets absorbed or passes through the skin.

Topical contact sensitizers can treat certain skin conditions but are rarely used in the U.K.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

The nail matrix has a reduced immune response, protecting it from autoimmunity.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

A condition with certain scalp changes may come before acne keloidalis nuchae and other similar hair loss disorders.

DM and AA may share a common cause.

Researchers made a mouse model with curly hair and hair loss by editing a gene.